TrialInvestigational new drugs2007

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.

Quincy S C Chu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.